Fastest Growing Biotech Stocks
| Price ($) | Market Cap ($B) | Revenue Growth (%) | |
| Beam Therapeutics Inc. ( BEAM) | 58.68 | 4.0 | 851,000 |
| Vir Biotechnology Inc. ( VIR) | 25.23 | 3.3 | 46,770 |
| Syndax Pharmaceuticals Inc. ( SNDX) | 17.81 | 1.0 | 33,300 |
Full Answer
What are the top 5 biotech stocks?
Best biotech stocks 1 Axsome Therapeutics. Axsome's lead candidate drug, which it calls AXS-05, targets depression and Alzheimer’s disease-related agitation. 2 Exelixis. Exelixis has developed four drugs that are already on the market. ... 3 Novavax. ... 4 Regeneron Pharmaceuticals. ... 5 Vertex Pharmaceuticals. ...
What are the largest biotech companies?
One of the largest and most stable biotech companies, Pfizer is largely known as a big pharma player, but it has invested billions of dollars into its biotech business. This company is a corporate juggernaut, ranked 57th in Fortune’s 2018 ranking of largest U.S. corporations by total revenue. Pfizer’s scale makes it a pretty stable investment.
Are biotechs buy-and-hold stocks?
The best biotech companies are well-positioned to deliver tremendous returns over long periods of time, making them well-suited for buy-and-hold investors. Keith Speights owns shares of Bristol Myers Squibb and Vertex Pharmaceuticals.
How do you rank biotech stocks based on revenue growth?
These are the top biotech stocks as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly YOY percentage revenue growth and their most recent quarterly YOY earnings-per-share (EPS) growth. Both sales and earnings are critical factors in the success of a company.
See more
What is the best biotech stock right now?
8 best biotech stocks to buy in 2022:Alkermes PLC (ALKS)BioMarin Pharmaceutical Inc. (BMRN)CRISPR Therapeutics AG (CRSP)Exelixis Inc. (EXEL)Global Blood Therapeutics Inc. (GBT)Ionis Pharmaceuticals (IONS)Sarepta Therapeutics Inc. (SRPT)Vir Biotechnology Inc (VIR)
What is the number 1 biotech company?
Johnson & JohnsonLargest Biotech companies by Market Cap#NameC.1Johnson & Johnson 1JNJ🇺🇸2Pfizer 2PFE🇺🇸3Roche 3ROG.SW🇨🇭4Eli Lilly 4LLY🇺🇸56 more rows
Is biotech a good stock to invest in?
Biotech stocks were some of the best performers at the start of the pandemic. More recently, though, they've vastly underperformed the broader market. Case in point: In 2021, the SPDR S&P Biotech (XBI) lost 20.5%, compared to the S&P 500's 26.9% gain.
What biotech stock is Jeff Bezos investing in?
Bezos has funded anti-aging research before — in 2018 he invested in Unity Technologies, a biotech company whose goal is to make anti-aging therapies.
What is the biggest biotech company in the world?
Johnson & JohnsonRankingsRankCompanyMarket Cap in 2020 (USD billions)1Johnson & Johnson NYSE: JNJ399.992 1Roche SIX: ROG291.123 2Pfizer NYSE: PFE208.114 1Novartis NYSE: NVS202.0940 more rows
What is the largest biotech company in the US?
1. Amgen, Inc.The Country's Biggest Biotechs... The Country's Biggest Biotechs...Amgen, Inc. Amgen, Inc.Gilead Sciences, Inc. Gilead Sciences, Inc.Celgene Corporation 3. Celgene Corporation.Biogen, Inc. Biogen, Inc.Regeneron Pharmaceuticals, ... ... CSL Limited 6. ... Alexion Pharmaceuticals, In...More items...•
What is the best pharmaceutical stock?
Best Pharmaceutical Stocks to BuyPfizer (NYSE: PFE) Industry Giant With Consistently Strong Dividends. ... AbbVie (NYSE: ABBV) ... Bristol-Myers Squibb (NYSE: BMY) ... Johnson & Johnson (NYSE: JNJ) ... Amgen (NASDAQ: AMGN) ... Gilead Sciences (NASDAQ: GILD) ... Merck & Co. ... Moderna (NASDAQ: MRNA)More items...
Who is the best biotech analyst?
In the 2019 StarMine Analyst Awards from Refinitiv, Dr. Phipps was ranked the No. 1 earnings estimator in biotechnology and No. 3 across all industries.
Is Regeneron a good stock to buy now?
The stock carries a perfect 99 Earnings Per Share Rating. This measures a company's earnings strength against all others in the market. Regeneron's earnings have leapt 260%, 84% and 149% in the past three quarters on equally impressive sales growth of 163%, 51% and 104%.
What stock is Elon Musk buying?
A 13D filing with the Securities and Exchange Commission on April 5 showed that Musk, who is chief executive of Tesla Inc. TSLA, +2.39% and founder of SpaceX, bought his 73.12 million shares of Twitter, or 9.1% stake, at a weighted average price of $36.157, according to a MarketWatch analysis of the data.
What biotech company did Warren Buffett invest in?
Warren Buffett's Berkshire Hathaway has bought 648,447 shares of Biogen at a combined worth of $192.4 million ahead of the FDA filing of a controversial Alzheimer's drug.
What stocks did Jeff Bezos buy recently?
Keep reading to see what other surprising companies the famous billionaire is investing in.EverFi. In April 2017, Bezos invested $190 million from his personal cash flow during a Series D funding round for EverFi. ... General Assembly. ... MakerBot. ... NextDoor. ... Plenty. ... Airbnb. ... Grail. ... Juno Therapeutics.More items...
What is biotech company?
What exactly is a biotech? It’s a company that uses living organisms (for example, bacteria or enzymes) to make drugs. This use of living organisms differentiates biotechs from pharmaceutical companies, which use chemicals to develop drugs.
What is the difference between a biotech and a biotech?
In addition, a biotech with more experimental drugs in its pipeline (the term used to refer to all a company’s drugs that are in development) will tend to have less risk than a biotech with only one or a very few drug candidates. Another important thing to watch with biotechs is their financial positions.
What is the importance of biotech?
Another important thing to watch with biotechs is their financial positions. Most biotechs don’t achieve profitability until they successfully launch one or more drugs in the market. They require significant amounts of cash to fund operations and advance their pipeline candidates.
How much is AXS 05 worth?
If approved, AXS-05 as a depression treatment could be a blockbuster drug, with peak annual sales -- the highest dollar-volume of sales per year analysts project -- estimated at $2.6 billion.
How much is the Cystic Fibrosis market worth in 2025?
This is a massive market; according to Grand View Research, the Cystic Fibrosis market will grow to be worth $13.9 billion by the year 2025. Perhaps its control of this high-value market is the reason Vertex Pharmaceuticals has generated growth in profit of 43.15% annually.
Is medical innovation coming to an end?
Medical innovation isn’t coming to an end any time soon. Big pharma is overwhelmingly profitable, and innovation continues where profits are made. Opportunities like these are born every day. However, as with any other industry, investing in biotech stocks is all about making the right decisions, as not all stocks are created equal.
Why are biotech stocks so popular?
Biotech stocks are popular because, if these companies successfully bring a product to market, their stock price could double or more virtually overnight.
What is the hot area of biotech?
Look for a “hot” area of biotech. This means looking for a company that is doing research for a disease or condition that affects a large segment of the population. However, as an investor, these are the companies that you should be looking for because there will be a high demand for the company’s products.
What is the most risky sector to invest in?
One of the most fascinating and potentially risky sectors to invest in is the biotech sector. This is the sector that includes companies involved in the research and development of therapeutics and vaccines to relieve a myriad of conditions and diseases.
Is biotech a small cap company?
By contrast, a biotech company is primarily research-driven that are using science to develop a potential therapy or vaccine. Many of these companies are small-cap stocks that are not profitable. And even the small fraction of those that rarely pay a dividend.
Is biotech a profitable sector?
The final word on investing in bio tech stocks. Investing in biotech stocks can be one of the most profitable sectors for risk-tolerant investors. Biotech companies are engaged in research and development for life-threatening conditions.
Do biotech companies have one product?
Many biotech companies have one product candidate. However, that’s a high-risk, high-reward proposition for investors. If that product fails, a company might have no other way to recoup their R&D costs. But companies that have several products in development give themselves multiple bites at the apple.
Do biotech products have to be approved by the FDA?
However even when (and if) a drug makes it through that process, the product (s) still have to be approved by the U.S. Food & Drug Administration (FDA) before it can go to market.
Why is it difficult to analyze biotech stocks?
Because there are many biotech companies that do not generate revenue, or their revenue is minimal, it is difficult to analyze these companies based on their fundamentals. A simple screen based on current earnings, revenue, or any other financial figure would not show the whole value of a biotech company. Biotech stocks require a unique form of ...
Is biotech stock volatile?
Stocks in the biotech industry are highly volatile and difficult to analyze. Many biotech companies currently trading on the stock market have one or more drugs still completing the Food and Drug Administration (FDA) approval process. Drugs still in testing can have a big impact on a biotech company’s valuation.
What is biotech company?
Biotech companies create drugs that are derived from living organisms. It’s the cutting edge of the drug development space. Biotech companies are producing ground-breaking medications for previously untreatable diseases, like Hepatitis C, cancer, and rare genetic disorders.
How many clinical phase products does Pfizer have?
Pfizer has a ton of actively distributed products, and they also have a thriving clinical segment. Currently, Pfizer has 37 clinical-phase products developed from biological compounds. With so many clinical-phase drugs, the risk of failure is spread more evenly.
Where is Novocure based?
Novocure Ltd. ( NVCR) Novocure is the only international biotech firm on our list of best biotech stocks. The company is based in the United Kingdom island of Jersey, and it has a market cap of about $4.2 billion. Founded in 2000, Novocure does business in several major international markets, including the EU and Japan.
Is biotech a profitable business?
However, a noble pursuit is not necessarily a profitable one. The majority of biotech startups do not mature into profitable companies.
Is biotech stock profitable?
Even the best biotech stocks can be very volatile assets, and most companies aren’t even profitable! Share prices are more influenced by sentiment than substance, so you can’t evaluate a biotech stock simply by glancing at financials. To truly understand where a company is headed, you need to know what’s driving the stock.
Is Pfizer a biotech company?
Pfizer ( PFE) One of the largest and most stable biotech companies, Pfizer is largely known as a big pharma player, but it has invested billions of dollars into its biotech business. This company is a corporate juggernaut, ranked 57th in Fortune’s 2018 ranking of largest U.S. corporations by total revenue.
Should Investors Consider These Top Biotech Stocks Now? 3 Making Moves
Biotech stocks have become some of the hottest stocks on the market right now. Last year, coronavirus vaccine companies led the charge as the biotech industry outpaced the broader market. Over the past year, the Nasdaq Biotechnology Index has risen by over 36%. Notably, this is more than double the gains of the S&P 500 over the same period.
Gritstone Oncology
Gritstone is a clinical-stage biotech company that specializes in developing immunotherapies. Its therapies are focused on treating multiple types of cancer and infectious diseases. Most recently, the company has added a coronavirus vaccine to its development pipeline.
Precision BioSciences
Precision BioSciences is another top biotech company that is heating up right now. It is a clinical-stage company that primarily works via its proprietary genome editing platform, Arcus. It has been a busy time for the company over the past two weeks. To point out, DTIL stock shot up by over 29% during yesterday’s trading session.
Pacific Biosciences of California
Following that, we will be looking at Pacific Biosciences or PacBio for short. PacBio is a leading provider of high-quality, long-read genetic sequencing platforms and tools. Its flagship platform runs on its proprietary single molecule, real-time (SMRT) technology.
StockMarket.com
StockMarket.com is a global financial markets platform that strives to educate, inform, engage & empower people to take control of their current & future financial lives, so they can profit within the stock market today! We offer access to free stock quotes, stock charts, breaking stock news, top market stories, free stock analyst ratings, SEC filings, stock price history, corporate events, public company financials and so much more.
